Today Biotechnology Industry is a fast track. Dr. Lindsay Rosenwald has become a leading personality in this Industry. He is the founder of Paramount Group of Industries. Paramount Group started with the establishment of Paramount BioCapital in the year nineteen ninety one. The activities of the Paramount Companies are well-diversified. Dr. Lindsay Rosenwald contributed to the development of the Biotechnology Industry through his Paramount Group of Companies. Paramount Portfolio Companies are engaged in the advancement of Drug research and development. In this process Paramount Corporate Development helps and guides Paramount Portfolio Companies.
Another company of Dr. Lindsay Rosenwald known as Paramount BioSciences is having network across the globe in the field of HealthCare Investment and Development. This company also gives guidance to new comers in this field and has become Role model to them. Paramount BioCapital is engaged in financial services and venture capital and also a Registered Broker-Dealer. This company takes care of the financial requirements of the Paramount and its Portfolio Company. At present this company accumulated funds nearly worth $950,000,000 for paramount Group of Industries since its birth in the year nineteen ninety nine.
Regarding his academic career Dr. Lindsay Rosenwald completed his graduate from Abington High School in Pennsylvania in the year nineteen seventy seven and after that he did graduation in medicine from Temple University School of medicine. After completion of internship at Abington Medical Hospital he carried on private medical practice for about two years. Later in 1986 he shifted to Wall Street. There he made use of his combined knowledge in the spheres of medicine and finance. At that time very few people had the combination of knowledge of both the disciplines. Dr. Lindsay Rosenwald’s combination of knowledge in both medicine and finance laid fast tracks that today kept him on fore front of success in the field of Biotechnology and Finance.
During his career as an Entrepreneur he has funded a number of world famous companies. Paramount BioCapital was the first company which was funded by Dr. Lindsay Rosenwald. After that the expansion was very fast and there was a great increase in the number of companies managed by him. All the Paramount Group of Companies have worked with the main object of financing to help the research and development and advanced research in the field of Biotechnology. Dr. Lindsay Rosenwald’s Paramount Group of Industries has made grand success in the Drug invention. One example in the connection is Cougar Biotechnology, one of his groups of companies, that has been engaged in examining its application in the treatment of prostate cancer. This company was purchased by Johnson and Johnson Company at a huge amount of one billion dollars.
Dr. Lindsay Rosenwald also established Rosenwald Foundation which is charitable foundation and is engaged in research and development in drugs and clinical research. He is also acting as Director and CEO in many numbers of private and public companies across the globe. He formulated and sold way a number of companies with FDA’s approval. Polarx was taken over by Cell Therapeutics and Myraid Pharmaceuticals purchased Javelin Pharmaceuticals and Enzymed Corporation was acquired by Albany Molecular. The secret of his success is acquisition of combined knowledge and experience in the fields of medicine and finance.
His investment portfolio speaks volumes about his vision orientation and forward thinkging. His strong belief is that there will be a tremendous growth in the area of biotechnology in the coming twenty years. The rate at which the industry is going, it is sure that we will see a very good number of changes. According to Rosenwald, upcoming medical discoveries will come via small biotech businesses, which are concentrated in, on producing only a few products, as opposed to a huge biotech organization, which has many projects in work at once. He believes the two most pressing issues we encounter these days are heart disease and cancer.
No related posts.
Lindsay Rosenwald is the one person who is been giving his best efforts for the benefit of Bio technology. There are few people who are changing the world with their honest vision. Lindsay Rosenwald, is one such person who is with great vision and with passion towards developing life saving drugs for the man kind. I am really impressed to see his success story. His investment portfolio speaks volumes about his focus towards developing this wonderful industry.
I agree with the comments made so far about Lindsay Rosenwald. He is definitely an inspiration for the coming generation. Bio technology is going to be the future research area. Contributing to such an industry is a note worthy. Lindsay Rosenwald is definitely going to make good number of followers in the coming future.
I know Lindsay Rosenwald as a person. Rosenwald left his private practice in 1986 to go to Wall Street where he took on a position as a Physician / Analyst, a really exclusive position with just a few individuals doing it at the time. Even though some doubted if he could thrive in this position, he showed those that doubted him that he was extremely proficient at investments. He had a passion for improving venture capital open to the health care industry and that’s largely why he worked there. He received great respect in his brand new position, and although he missed his old private practice, he recognized this is where he actually belonged. He also worked for a private investment company, DH Blair Co as the Controlling Director of Finance, but left eventually to concentrate on a new endeavor.
[...] Lindsay Rosenwald completed his Bachelor of Science and a Finance degree for Pennsylvania University in 1972 and [...]
[...] continued to mention how Dr. Lindsay Rosenwald established a private practice for two and a half years prior to coming to Wall Street as a [...]
[...] article proceeds to mention Lindsay Rosenwald’s background as a venture capitalist, and his work in the finance and medical industries. [...]
[...] Lindsay Rosenwald , founder of Paramount Biotech, made it profitable by acquiring other biotech companies and making them part of his portfolio. He has created or financed over 40 firms – over 25 of which have been in the past 3 years. He creates these businesses by focusing on the growth of both corporate and biotechnology portions. Paramount Capital is a conglomerate of businesses including: Paramount biosciences,Paramount Corporate Development and Paramount BioCapital. All of these businesses are separate organizations, but interact to aid each other. The firms that Rosenwald controls have licensed or acquired over 100 experimental phase medications. [...]
Lindsay is one of the few people who changed the status quo in the biotechnology market by setting up various companies that are involved in clinical research and drug development.
Nice to know more about him
the person who thinks of the future of the bio-technology can be the foremost already named as Dr.lindsay rosenwald.Mounted at the highest point of the world by providing his services up to, the best whether in the form of the providing funds to the organizations that deals with the same as that which the paramount does or in the core field of research.The thing that speaks of the future mind scope of lindsay is the trust which he has on the small biotehnology based companies which would further help to improve the increasingly filing cases of the heart diseases and the cancers.
I agree with the comments made so far about Lindsay Rosenwald. He is definitely an inspiration for the coming generation. Bio technology is going to be the future research area. Contributing to such an industry is a note worthy. Lindsay Rosenwald is definitely going to make good number of followers in the coming future.
[...] continued to mention how Dr. Lindsay Rosenwald established a private practice for two and a half years prior to coming to Wall Street as a [...]
this is the right person who is best eligible for the people who want to make out their career in this case and also he has become an brand to be an example is not an easy task but being a member of student of some other field even then he joined did something of his interest this itself shows how enjoyable i the lindsay’s work
[...] Linsay Rosenwald has regular and close interaction with the leading US sell-side and buy-side organizations that consist of notable health care individuals, with whom Paramount’s hedge funds put money into the deals not directly involving this company by itself. Paramount’s staff has real-time perception of health-related capital markets, which resulted in over $400 million funds for Portfolio Corporations in 2009 year alone, including $200 million by Paramount. This includes $47 million for Cougar Biosciences along with SG Cowen, $37 million for Ziopharm Oncology, $22 MM for Chelsea Therapeutics and $16 million for Innovive Pharmaceuticals. Many of the top health care funds financed in Paramount in 2010, which continues to be a good indication for the development of medical and life sciences industries. [...]
Dr. Lindsay Rosenwald sits on the Board of Directors for the Republican Jewish Coalition. As a board member, his biography appears on the coalition’s website, http://www.rjchq.org. This biography details Dr. Lindsay Rosenwald’s current professional status as the senior managing director of Paramount Capital Asset Management, Inc., which he also co-founded. The company specializes in financing for the biotechnology field, which includes private equity, hedge funds, and venture capital.
The Muckety Maps website includes a map for Dr. Lindsay Rosenwald. It uses a diagram to show his relationship with the Republican Jewish Coalition and Paramount Capital Asset Management, Inc.
As a member of the Wellness.com community, Dr. Lindsay Rosenwald’s credentials and current practice are displayed in his Wellness.com profile. He graduated from Temple University Medical School and is currently a general practitioner in New York City. Dr. Lindsay Rosenwald offers many services, including physical examinations, cholesterol testing, fitness programs, and skin biopsies.
Dr. Lindsay Rosenwald is an active member of the NyICECATS. The NyICECATS is a Jewish Orthodox youth hockey organization that includes an adult team. When Dr. Lindsay Rosenwald attended the third and fourth annual Captain’s Dinner in New York City on March 12th he was presented with gifts by Neil Herskowitz who is the Director of Manhattan Pharmaceuticals, Inc. The gifts included a Bauers 190. During the dinner, Dr. Lindsay Rosenwald spoke and said he was committed to playing hockey at the Piers for 25 more years. The celebration ended with the “Golden Balls” award ceremony.
The Huffington Post’s FundRace of 2008 reports Dr. Lindsay Rosenwald’s donation to the McCain Victory Committee, which amounted to $61,800.
Chelsea’s compound, has demonstrated superiority in terms of each safety and efficacy
in excess of Methotrexate, the current remedy standard for RA, which continues to
be identified to elevate liver enzymes in quite a few people in addition to Lindsay
Rosenwald. Extremely important Capital licensed these technologies on the University
of South Alabama and assembled a world-class management team to help optimize its
formulation and advance the development of this and other compounds.
A different academic license from Important is a profile of organic arsenic trioxide
compounds licensed through the MD Anderson Cancer Center. This FDA approved
compound progressed from IND to NDA in about 30 months and this could be the
quickest regulatory approval inside FDA historical past. Trisenox, an inorganic
alternative of arsenic trioxide, which can item creates cardiac abnormalities at large
doses. By contrast using the inorganic edition, natural and organic arsenic trioxide does
not display evidence of these problems, even when applied at doses dual ten periods
larger than Trisenox. To leverage that advantage, Dr. Lindsay Rosenwald founded
Ziopharm Oncology to advance this organic and natural arsenic compound, ZIO-
101, to deal with cancers, which include solid tumors, exactly where mega dosing has
verified efficient. Ziopharm Oncology, as one of numerous Paramount’s portfolio firms,
subsequently has in-licensed and is developing several other anti-cancer agents.
Another Vital profile corporation, founded and managed by Lindsay Rosenwald
M.D., is Keryx Bio pharmaceuticals. It really is creating a compound termed Sulonex,
which can be an oral treatment for diabetic nephropathy. It was licensed in the Alfa
Wassermann Group, a privately held pharmaceutical firm in Bologna, Italy. If authorized,
Sulonex will probably be marketed to 15 million persons diagnosed with Kind two
diabetes as well since the one to 2 million affected individuals with Type 1 diabetes.
Extremely important Bio Sciences, LLC, a global pharmaceutical development and
wellness care investment corporation, was founded and managed by Dr. Lindsay A.
Rosenwald in 19th centuries. The organization facilitates drug development, scientific
assistance and dedicates itself to locating and creating novel therapeutic medicines with
big potential. By assessing promising drug candidates throughout the world, Important
has been able to create, nurture, and help far more than 40 lifestyle sciences corporations,
academic centers, biotechnology and pharmaceutical firms over the past 19 years, which
includes 20 inside the final 48 months. Present Portfolio Corporations have more than 40
solution candidates advancing through clinical trials.
Special method to bio tech purchase: Business and solution growth are just two
pieces inside Very important puzzle. An affiliate of extremely important Bio
Sciences – Paramount with the Lindsay Rosenwald Bio Cash, Inc., is a FINRA
registered broker-dealer that, amongst other actions, raises capital with the Very
important Profile Companies. It raised over $1 billion for the Portfolio Corporations;
a number of times that sum have become raised for Vital Businesses by other entities.
[...] in the financial sector as an investment banker, venture capitalist, and hedge fund manager.Dr. Lindsay Rosenwald got his interest in biotechnology fueled from his first company, Paramount Biocapital. This [...]
[...] has been almost twenty years since Dr. Lindsay Rosenwald started his career in medicine and the biosciences, in those years he has become known as a man of [...]